UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055876
Receipt number R000063860
Scientific Title Web-based survey of physicians' perceptions and actual conditions of agitation associated with Alzheimer's disease.
Date of disclosure of the study information 2024/10/18
Last modified on 2025/10/20 16:18:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Web-based survey of physicians' perceptions and actual conditions of agitation associated with Alzheimer's disease.

Acronym

Survey of physicians' perceptions of Alzheimer's agitation.

Scientific Title

Web-based survey of physicians' perceptions and actual conditions of agitation associated with Alzheimer's disease.

Scientific Title:Acronym

Survey of physicians' perceptions of Alzheimer's agitation.

Region

Japan


Condition

Condition

Alzheimer's dementia

Classification by specialty

Neurology Geriatrics Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Surveying symptoms physicians recall as "agitation associated with Alzheimer's dementia".
Investigating the actual prescribing of antipsychotic drugs.

Basic objectives2

Others

Basic objectives -Others

N/A

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. physician background information
- Gender, age, department, number of beds, type of facility, physician's professional qualifications and affiliations
2. actual condition of AD patient care
-Number of AD patients and all patients in the last month, type of treatment for AD patients in the last month, medical coordination, names of drug classes and their ranking of newly prescribed drugs for AD patients, reasons for not newly prescribing antipsychotic drugs for AD patients (in Japanese).
3. recognition of BPSD
Recognition of BPSD rating scales and definitions, frequency of use of BPSD rating scales, frequency of BPSD occurrence in AD patients, types and ranking of BPSDs reported as difficult to cope with by caregivers of AD patients, BPSDs difficult to cope with and their ranking
4. recognition of AAD
Symptoms recalled by "agitation",number of patients with AAD treated in the last month
5. antipsychotic prescriptions
Frequency of prescribing for AAD, reasons for not prescribing for AAD, average duration of prescriptions, criteria for starting prescriptions, importance of prescribing and its ranking, side effects of concern and its ranking, prescribing policy when symptoms are stable, explanation to caregivers, evaluation of effectiveness of antipsychotic drugs, discontinuation Reasons for discontinuation

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Psychiatrist, Neurologist, Neurosurgeon, General Physician
Physicians who have treated at least 10 AD patients in the last 1 month

Key exclusion criteria

none

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Koichi
Middle name
Last name Shimizu

Organization

Otsuka Pharmaceutical Co.,Ltd.

Division name

Medical Affairs

Zip code

108-8241

Address

Shinagawa Grand Central Tower 2-16-4 Konan,Minato-ku, Tokyo 108-8242, Japan

TEL

03-6717-1400

Email

Shimizu.Kochi@otsuka.jp


Public contact

Name of contact person

1st name Koichi
Middle name
Last name Shimizu

Organization

Otsuka Pharmaceutical Co.,Ltd.

Division name

Medical Affairs

Zip code

108-8241

Address

Shinagawa Grand Central Tower 2-16-4 Konan,Minato-ku, Tokyo 108-8242, Japan

TEL

03-6717-1400

Homepage URL


Email

Shimizu.Kochi@otsuka.jp


Sponsor or person

Institute

Otsuka Pharmaceutical Co.,Ltd.

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Otsuka Pharmaceutical Co., Ltd. Research Division Research Ethics Committee

Address

463-10 Kagasuno, Kawauchi-cho, Tokushima City, Tokushima Prefecture

Tel

088-665-2126

Email

Suzuki.Takashi@otsuka.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

515

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 10 Month 11 Day

Date of IRB

2024 Year 10 Month 10 Day

Anticipated trial start date

2024 Year 10 Month 15 Day

Last follow-up date

2024 Year 10 Month 18 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Surveying symptoms physicians recall as "agitation associated with Alzheimer's dementia"
Investigating the actual prescribing of antipsychotic drugs


Management information

Registered date

2024 Year 10 Month 18 Day

Last modified on

2025 Year 10 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063860